Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma

Detalles Bibliográficos
Autores principales: Yan, Yibing, McArthur, Grant, Hamid, Omid, Puzanov, Igor, Gonzalez, Rene, Gajewski, Thomas, Wang, Yulei, Wongchenko, Matthew, Choong, Nicholas, Ribas, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108918/
http://dx.doi.org/10.1186/1479-5876-12-S1-O12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108918/
http://dx.doi.org/10.1186/1479-5876-12-S1-O12

Ejemplares similares